The importance of age over radioiodine avidity as a prognostic factor in differentiated thyroid carcinoma with distant metastases

Thyroid

Volumn 19, Issue 3, 2009, Pages 227-232

  Mihailovic, Jasna ^a   Stefanovic, Ljubomir ^a   Malesevic, Milica ^a   Markoski, Branko ^b  

^a ONCOLOGY INSTITUTE OF VOJVODINA   (Serbia)

^b UNIVERSITY OF NOVI SAD   (Serbia)

Author keywords

[No Author keywords available]

Indexed keywords

IODINE 131; THYROGLOBULIN;

ADOLESCENT; ADULT; AGED; ARTICLE; BONE METASTASIS; CANCER PALLIATIVE THERAPY; CANCER SURVIVAL; CHILD; DRUG UPTAKE; EXTERNAL BEAM RADIOTHERAPY; FEMALE; HUMAN; KAPLAN MEIER METHOD; LUNG METASTASIS; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MALE; METASTASIS; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; THYROGLOBULIN BLOOD LEVEL; THYROID CARCINOMA; THYROID FOLLICULAR CARCINOMA; THYROID PAPILLARY CARCINOMA; THYROIDECTOMY; TREATMENT OUTCOME; UNIVARIATE ANALYSIS; WHOLE BODY SCINTISCANNING;

ADOLESCENT; ADULT; AGED; AGING; ANTINEOPLASTIC AGENTS; CARCINOMA, PAPILLARY, FOLLICULAR; CHILD; DISEASE PROGRESSION; FEMALE; HUMANS; IODINE RADIOISOTOPES; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; NEOPLASM METASTASIS; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; SURVIVAL; THYROID NEOPLASMS; YOUNG ADULT;

EID: 62249119221     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.2008.0186     Document Type: Article

References (29)

1. Sampson E, Brierley JD, Le LW, Rotstein L, Tsang RW 2007 Clinical management and outcome of papillary and follicular (differentiated) thyroid cancer presenting with distant metastases. Cancer 110:1451-1456.
2. Carling T, Udelsman R 2005 Section 2: Thyroid tumors. In: DeVita VT Jr, Hellman S, Rosenberg SA (eds) Cancer Principles & Practice of Oncology. 7th edition. Volume 1. Lippincott Williams & Wilkins, Philadelphia, pp 1502-1520.
3. Shoup M, Stojadinovic A, Nissan A, Ghossein RA, Freedman S, Brennan MF, Shah JP, Shaha AR 2003 Prognostic indicators of outcomes in patients with distant metastases from differentiated thyroid carcinoma. J Am Coll Surg 197:192-197.
4. Jameson JL, Weetman AP 2005 Disorders of the thyroid gland. In: Kasper LD, Braunwald E, Fauci AS, Hauser SL, Longo DL, Jameson JL (eds) Harrison's Principles of Internal Medicine. 16th edition. McGraw-Hill Companies, New York, pp 2104-2127.
5. Driedger AA, McDonald TJ 2003 Thyroid disorders. In: Leslie WD, Greenberg ID. Nuclear Medicine. Landes Bioscience, Georgetown, TX, pp 260-275.
6. Stefanovic LJ, Vojicic J, Malesevic M, Mihailovic J, Srbovan D 2001 Treatment outcome in patients with differentiated thyroid carcinoma and distant metastases. J BUON 6:263-269.
7. Stefanovic LJ, Guduric B, Sljapic N, Babic J, Miljkovic LJ, Malesevic M, Bogdanovic J. 1994 Protocols of diagnostics, treatment and control of malignant thyroid tumors at the Institute of Oncology in Sremska Kamenica. Onc Arch 2:101-107 (in Serbian).
8. DeLellis RA, Lloyd RV, Heitz PU, Eng C (eds) 2004 World Health Organization Classification of Tumours. Pathology & Genetics. Tumours of Endocrine Organs. IARC Press, Lyon, France, pp 49-133.
9. McDougall IR 2006 Differentiated thyroid cancer. In: Management of Thyroid Cancer and Related Nodular Disease. Springer-Verlag, London, pp 163-281.
10. Oliveira MJ, Pereira de Oliveira JM 2007 Treatment of differentiated thyroid carcinoma. In: Eary JF, Brenner W (eds) Nuclear Medicine Therapy. Informa Healthcare USA, Inc., New York, pp 45-75.
11. Goldsmith SJ 2001 Thyroid carcinoma. In: Khalikhali I, Maublant JC, Goldsmith SJ (eds) Nuclear Oncology: Diagnosis & Therapy. Lippincott Williams & Wilkins, Philadelphia, pp 197-219.
12. Pacini F, Cetani F, Miccoli P, Mancusi F, Ceccarelli C, Lippi F, Martino E, Pinchera A 1994 Outcome of 309 patients with metastatic differentiated thyroid carcinoma treated with radioiodine. World J Surg 18:600-604.
13. Schlumberger M, Challeton C, De Vathaire F, Travagli JP, Gardet P, Lumbroso JD, Francese C, Fontaine F, Ricard M, Parmentier C 1996 Radioactive iodine treatment and external radiotherapy for lung and bone metastases from thyroid carcinoma. J Nucl Med 37:598-605.
14. Lin JD, Huang MJ, Juang JH, Chao TC, Huang BY, Chen KW, Chen JY, Li KL, Chen JF, Ho YS 1999 Factors related to the survival of papillary and follicular thyroid carcinoma patients with distant metastases. Thyroid 9:1227-1235.
15. Dietlein M, Moka D, Schicha 2005 Radioiodine therapy for thyroid cancer. In: Biersack HJ, Grunwald F (eds) Thyroid Cancer. Second edition. Springer-Verlag, Berlin, pp 95-126.
16. Schlumberger M, Pacini F 2006 Thyroid Tumours. Editions Nucleon, Paris.
17. Pelizzo MR, Boschin IM, Toniato A, Piotto A, Pagetta C, Gross MD, Al-Nahhas A, Rubello D 2007 Papillary thyroid carcinoma: 35-year outcome and prognostic factors in 1858 patients. Clin Nucl Med 32:440-444.
18. Sisson JC, Giordano TJ, Jamadar DA, Kazerooni EA, Shapiro B, Gross MD, Zempel SA, Spaulding SA 1996 131-I treatment of micronodular pulmonary metastases from papillary thyroid carcinoma. Cancer 78:2184-2192.
19. Dinneen S, Valimaki M, Bergstralh E, Goellner J, Gorman C, Hay ID 1995 Distant metastases in papillary thyroid carcinoma: 100 cases observed at one institution during 5 decades. J Clin Endocrinol Metab 80:2041-2045.
20. Haq MS, Harmer C 2006 Non-surgical management of thyroid cancer. In: Mazzaferri EL, Harmer C, Mallick UK, Kendall-Taylor P (eds) Practical Management of Thyroid Cancer. A Multidisciplinary Approach. Springer-Verlag, London, pp 171-191.
21. Casara D, Rubello D, Saladini G, Gallo V, Masarotto G, Busnardo B 1991 Distant metastases in differentiated thyroid cancer: long-term results of radioiodine treatment and statistical analysis of prognostic factors in 214 patients. Tumori 77:432-436.
22. Grünwald F, Kälicke T, Feine U, Lietzenmayer R, Scheidhauer K, Dietlein M, Schober O, Lerch H, Brandt-Mainz K, Burchert W, Hiltermann G, Cremerius U, Biersack H-J 1999 Fluorine-18 fluorodeoxyglucose positron emission tomography in thyroid cancer: results of a multicentre study. Eur J Nucl Med 26:1547-1552.
23. Ruiz Franco-Baux JV, Borrego Dorado I, Gomez Camarero P, Rodriguez Rodriguez JR, Vazquez Albertino RJ, Navarro Gonzalez E, Jimenez AR 2005 F-18-fluordeoxyglucose positron emission tomography on patients with differentiated thyroid cancer who present elevated human serum thyroglobulin levels and negative I-131 whole body scan. Rev Esp Med Nucl 24:5-13.
24. 18F] fluoro-2-deoxy-d-glucose-positron emission tomography scanning. J Clin Endocrinol Metab 91:498-505.
25. Feine U, Lietzenmayer R, Hanke J-P, Held J,Wörhle H,Müller-Schauenburg W 1996 Fluorine-18-FDG and iodine-131-iodide uptake in thyroid cancer. J Nucl Med 37:1468-1472.
26. Grünwald F, Menzel C, Bender H, Palmedo H, Otte R, Fimmers R, Risse J, Biersack HJ 1998 Redifferentiation therapy-induced radioiodine uptake in thyroid cancer. J Nucl Med 39:1903-1906.
27. Simon D, Köhrle J, Reiners C, Börner AR, Schmutzler C, Mainz K, Goretzki PE, Röher HD 1998 Redifferention therapy with retinoids: therapeutic option for advanced follicular and papillary throat carcinoma. World J Surg 22:569-574.
28. Börner AR, Petrich T, Weckesser E, Fricke H, Hofmann M, Otto D, Weckesser M, Langen KJ, Knapp WH 2002 Monitoring isotretinoin therapy in thyroid cancer using 18F-FDG PET. Eur J Nucl Med Mol Imaging 29:231-236.
29. Simon D, Körber C, Krausch M, Segering J, Groth P, Görges R, Grünwald F, Müller-Gärtner HW, Schmutzler C, Köhrle J, Röher HD, Reiners C 2002 Clinical impact of retinoids in redifferentiation therapy of advanced thyroid cancer: final results of a pilot study. Eur J Nucl Med Mol Imaging 29:775-782.